Page last updated: 2024-11-05

trimethadione and Stevens-Johnson Syndrome

trimethadione has been researched along with Stevens-Johnson Syndrome in 1 studies

Trimethadione: An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)
trimethadione : An oxazolidinone that is 1,3-oxazolidine-2,4-dione substituted by methyl groups at positions 3, 5 and 5. It is an antiepileptic agent.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SHAFFER, B1
MORRIS, P1

Other Studies

1 other study available for trimethadione and Stevens-Johnson Syndrome

ArticleYear
Severe erythema multiforme of the pluriorificial type, Stevens-Johnson syndrome, resulting in blindness in a patient treated with trimethadione.
    Pediatrics, 1948, Volume: 2, Issue:1

    Topics: Blindness; Erythema Multiforme; Humans; Stevens-Johnson Syndrome; Trimethadione

1948